CompaniesSchwartz Pharma

Schwartz Pharma

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (3)

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

27

By Phase

PHASE2: 2PHASE1: 1

By Status

WITHDRAWN: 2TERMINATED: 1

Clinical Trials Pipeline3 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

Today

Hover over trial bars to see details

Recent Trials

NCT02834754Lead Sponsor

Vedolizumab Post Op Study

PHASE2Withdrawn

Started: Dec 1, 2018 · Completed: May 1, 2019

NCT02619669Lead Sponsor

Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer

PHASE1Withdrawn

Started: Apr 20, 2017 · Completed: Jun 14, 2019

NCT00225758Lead Sponsor

Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy

PHASE2Terminated

27 participants

Started: Jan 31, 2006 · Completed: Oct 31, 2011

Related Companies

Ucb

acquired